The efficacy and safety of ZN-c3 is currently being evaluated in adult women with recurrent or persistent uterine serous carcinoma in an ongoing open-label, multicenter phase 2 study ...

Objective To determine the outcomes of surgically staged patients with I-IIIA uterine papillary serous carcinoma (UPSC) and clear cell carcinoma (CCC) of the uterus treated at Indiana University and ...

5590 Background: Adjuvant chemotherapy (CT) and radiotherapy (RT) are often part of management of early stage uterine papillary serous (UPSC) and clear cell carcinoma (UCC), though their benefit ...

Most uterine cancers have excellent five-year survival rates – up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 ...